Soleil Boughton - 13 Jun 2025 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Role
Chief Legal Officer
Signature
/s/ Alexandra Cotter Wilkins, Attorney-in-Fact
Issuer symbol
HIMS
Transactions as of
13 Jun 2025
Net transactions value
-$1,754,979
Form type
4
Filing time
17 Jun 2025, 20:06:42 UTC
Previous filing
29 May 2025
Next filing
01 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Boughton Soleil Chief Legal Officer 2269 CHESTNUT STREET, #523, SAN FRANCISCO /s/ Alexandra Cotter Wilkins, Attorney-in-Fact 17 Jun 2025 0001837817

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HIMS Class A Common Stock Options Exercise +41,420 +27% 194,614 13 Jun 2025 Direct F1
transaction HIMS Class A Common Stock Tax liability $1,291,685 -23,282 -12% $55.48 171,332 13 Jun 2025 Direct
transaction HIMS Class A Common Stock Sale $309,617 -5,451 -3.2% $56.80 165,881 16 Jun 2025 Direct F2
transaction HIMS Class A Common Stock Sale $153,677 -2,572 -1.6% $59.75 163,309 17 Jun 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HIMS Restricted Stock Unit Options Exercise $0 -10,916 -25% $0.000000 32,747 13 Jun 2025 Class A Common Stock 10,916 Direct F1, F3
transaction HIMS Restricted Stock Unit Options Exercise $0 -12,223 -12% $0.000000 85,561 13 Jun 2025 Class A Common Stock 12,223 Direct F1, F4
transaction HIMS Restricted Stock Unit Options Exercise $0 -12,099 -8.3% $0.000000 133,089 13 Jun 2025 Class A Common Stock 12,099 Direct F1, F5
transaction HIMS Restricted Stock Unit Options Exercise $0 -6,182 -6.2% $0.000000 92,743 13 Jun 2025 Class A Common Stock 6,182 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.
F2 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.
F3 The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2022.
F4 The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2023.
F5 The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024.
F6 The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2025.